Bank of New York Mellon
GENE

Bank of New York Mellon’s Genetic Technologies Ltd. GENE Stock Holding History

Bank of New York Mellon’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,736
Closed -$42K – 4359
2017
Q1 		$42K Buy
+1,736
New +$39.6K ﹤0.01% 4160

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

Bank of New York Mellon's GENE Position: Q2 2017 in Review

Bank of New York Mellon sold out of Genetic Technologies Ltd. (GENE) in Q2 2017, closing a stake of 1,736 shares — an estimated $42K sold.

Bank of New York Mellon first reported a position in GENE in Q1 2017 and held it in 1 quarter. The position peaked at $42K in Q1 2017. 17 funds tracked by Wall St. Rank hold GENE as of Q2 2017.

  • Bank of New York Mellon reported no remaining Genetic Technologies Ltd. position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 1,736 Genetic Technologies Ltd. shares in Q2 2017, an estimated $42K.
  • Bank of New York Mellon first reported a position in Genetic Technologies Ltd. in Q1 2017 and held it in 1 quarter.
  • Bank of New York Mellon's Genetic Technologies Ltd. position peaked at $42K in Q1 2017.
  • 17 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.